SITE012-0272

SITE012 (BRA) › SITE012-0272

SITE012-0272

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-07-18

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-03-15 (study day 43); relationship: RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.